APPLICATION OF CRYSTALLOGRAPHIC AND MODELING METHODS IN THE DESIGN OF PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITORS

被引：157
|
作者：
EALICK, SE
BABU, YS
BUGG, CE
ERION, MD
GUIDA, WC
MONTGOMERY, JA
SECRIST, JA
机构：
[1] BIOCRYST INC,BIRMINGHAM,AL 35205
[2] CIBA GEIGY CORP,SUMMIT,NJ 07901
[3] SO RES INST,BIRMINGHAM,AL 35255
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1991年 / 88卷 / 24期
关键词：
D O I：
10.1073/pnas.88.24.11540
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Competitive inhibitors of the salvage pathway enzyme purine-nucleoside phosphorylase (purine-nucleoside:orthophosphate ribosyltransferase, EC 2.4.2.1) have been designed by using the three-dimensional structure of the enzyme as determined by x-ray crystallography. The process was an iterative one that utilized interactive computer graphics, Monte Carlo-based conformational searching, energy minimization, and x-ray crystallography. The proposed compounds were synthesized and tested by an in vitro assay. Among the compounds designed and synthesized are the most potent competitive inhibitors of purine nucleoside phosphorylase thus far reported.
引用
收藏
页码：11540 / 11544
页数：5
相关论文
共 50 条
  • [21] Purine nucleoside phosphorylase inhibitors in T-cell malignancies
    Bantia, S
    Kilpatrick, JM
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (02) : 243 - 247
  • [22] CALCULATION OF RELATIVE BINDING AFFINITIES OF PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITORS
    CARSON, M
    YANG, Z
    BABU, YS
    MONTGOMERY, JA
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1995, 51 : 536 - 540
  • [23] Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site
    Hampson, Laura J.
    Arden, Catherine
    Agius, Loranne
    Ganotidis, Minas
    Kosmopoulou, Magda N.
    Tiraidis, Costas
    Elemes, Yiannis
    Sakarellos, Constantinos
    Leonidas, Demetres D.
    Oikonomakos, Nikos G.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (23) : 7835 - 7845
  • [24] Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis
    Morris, PE
    Omura, GA
    CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (09) : 943 - 959
  • [25] BioCryst licenses purine nucleoside phosphorylase inhibitors from Torii
    不详
    BIOTECHNOLOGY LAW REPORT, 1996, 15 (04): : 619 - 619
  • [26] Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase
    Cui, Huaqing
    Ruda, Gian Filippo
    Carrero-Lerida, Juana
    Ruiz-Perez, Luis M.
    Gilbert, Ian H.
    Gonzalez-Pacanowska, Dolores
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) : 5140 - 5149
  • [27] Design and directed evolution of a dideoxy purine nucleoside phosphorylase
    Nannemann, David P.
    Kaufmann, Kristian W.
    Meiler, Jens
    Bachmann, Brian O.
    PROTEIN ENGINEERING DESIGN & SELECTION, 2010, 23 (08): : 607 - 616
  • [28] RATIONAL DESIGN OF QUINAZOLINE-BASED IRREVERSIBLE INHIBITORS OF HUMAN ERYTHROCYTE PURINE NUCLEOSIDE PHOSPHORYLASE
    DEMPCY, RO
    SKIBO, EB
    BIOCHEMISTRY, 1991, 30 (34) : 8480 - 8487
  • [29] PURINE METABOLITES IN ACTIVITY OF PURINE NUCLEOSIDE PHOSPHORYLASE
    FUSTE, R
    BOZAL, J
    REVISTA ESPANOLA DE FISIOLOGIA, 1976, 32 (03): : 199 - 204
  • [30] Synthesis and biological activity of a novel class of purine nucleoside phosphorylase inhibitors
    Morris, PE
    Elliott, AJ
    Walton, SP
    Williams, CH
    Montgomery, JA
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2000, 19 (1-2): : 379 - 404
12345